Louis Kayitalire serves as Executive at F-star Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Louis Kayitalire has executed 8 insider transactions totaling $9.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 8, 2023 involved selling 25,019 shares valued at $178.1K.
Louis Kayitalire currently holds 25,019 shares of F-star Therapeutics, Inc. (FSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis Kayitalire has been a net seller of FSTX stock. They have purchased $0 and sold $9.8K worth of shares.
Louis Kayitalire's most recent insider trade was on Mar 8, 2023, when they sold 25,019 shares at $7.12 per share.
Get notified when new Form 4 filings are submitted
| 29,236 |
| $7.12 |
| Discretionary |
| Nov 2, 2021 | FSTX | $266 | Sale | 39 | $6.81 | Discretionary |
| Nov 2, 2021 | FSTX | $171 | Sale | 25 | $6.85 | Discretionary |
| Oct 4, 2021 | FSTX | $463 | Sale | 64 | $7.23 | Discretionary |
| Jul 2, 2021 | FSTX | $8.9K | Sale | 1,054 | $8.43 | Discretionary |
| Feb 1, 2021 | FSTX | $0 | Award | 29,000 | $N/A | Discretionary |
| Nov 20, 2020 | FSTX | $0 | Award | 26,437 | $N/A | Discretionary |